ProfileGDS4718 / 230120_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 25% 39% 38% 54% 35% 39% 30% 25% 34% 39% 51% 37% 29% 45% 31% 40% 36% 34% 54% 28% 45% 33% 30% 35% 40% 37% 46% 30% 21% 37% 52% 29% 40% 36% 45% 25% 34% 33% 47% 45% 44% 53% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8170236
GSM549102patient 115, normal, homogenized [OPG study]4.3442725
GSM549104patient 119, normal, homogenized [OPG study]4.9226639
GSM549108patient 138, normal, homogenized [OPG study]4.968238
GSM549119patient 077, normal, homogenized [OPG study]5.7479454
GSM549133patient 032, cancer, homogenized [OPG study]4.7158635
GSM549139patient 042, cancer, homogenized [OPG study]4.9123139
GSM549099patient 107, normal, homogenized [OPG study]4.5455430
GSM549109patient 139, normal, homogenized [OPG study]4.3612825
GSM549110patient 046, normal, homogenized [OPG study]4.7128134
GSM549114patient 063, normal, homogenized [OPG study]4.9001639
GSM549122patient 082, normal, homogenized [OPG study]5.5504851
GSM549134patient 033, cancer, homogenized [OPG study]4.8264437
GSM549136patient 036, cancer, homogenized [OPG study]4.4585629
GSM549140patient 044, cancer, homogenized [OPG study]5.2022345
GSM549111patient 047, normal, homogenized [OPG study]4.5421531
GSM549113patient 057, normal, homogenized [OPG study]4.9308940
GSM549132patient 031, cancer, homogenized [OPG study]4.7806836
GSM549137patient 038, cancer, homogenized [OPG study]4.7022134
GSM549142patient 047, cancer, homogenized [OPG study]5.8812254
GSM549100patient 110, normal, homogenized [OPG study]4.4885928
GSM549107patient 135, normal, homogenized [OPG study]5.2184545
GSM549115patient 068, normal, homogenized [OPG study]4.6037733
GSM549116patient 072, normal, homogenized [OPG study]4.51630
GSM549120patient 078, normal, homogenized [OPG study]4.7537635
GSM549131patient 030, cancer, homogenized [OPG study]4.9232740
GSM549118patient 074, normal, homogenized [OPG study]4.8691837
GSM549129patient 027, cancer, homogenized [OPG study]5.3214746
GSM549123patient 088, normal, homogenized [OPG study]4.5192430
GSM549124patient 006, cancer, homogenized [OPG study]4.208321
GSM549126patient 015, cancer, homogenized [OPG study]4.8170537
GSM549128patient 025, cancer, homogenized [OPG study]5.6391652
GSM549103patient 117, normal, homogenized [OPG study]4.5401629
GSM549117patient 073, normal, homogenized [OPG study]4.9661340
GSM549138patient 041, cancer, homogenized [OPG study]4.8005736
GSM549141patient 045, cancer, homogenized [OPG study]5.172645
GSM549130patient 028, cancer, homogenized [OPG study]4.3648525
GSM549101patient 111, normal, homogenized [OPG study]4.7373734
GSM549105patient 128, normal, homogenized [OPG study]4.6931533
GSM549106patient 134, normal, homogenized [OPG study]5.2776147
GSM549112patient 048, normal, homogenized [OPG study]5.2142445
GSM549125patient 011, cancer, homogenized [OPG study]5.1912444
GSM549127patient 024, cancer, homogenized [OPG study]5.6853153
GSM549135patient 035, cancer, homogenized [OPG study]4.8119637